MedPath

Otsuka Pharmaceutical Netherlands B.V.

🇳🇱Netherlands
Ownership
Private
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

56

CIMA_AEMPS:49
EMA:7

Drug Approvals

Inaqovi

Authorization Status
Authorised
Approval Date
Sep 15, 2023
EMA

Lupkynis

Authorization Status
Authorised
Approval Date
Sep 15, 2022
EMA

Rxulti

Authorization Status
Authorised
Approval Date
Jul 26, 2018
EMA

Jinarc

Authorization Status
Authorised
Approval Date
May 27, 2015
EMA

Abilify Maintena

Authorization Status
Authorised
Approval Date
Nov 14, 2013
EMA

Samsca

Authorization Status
Authorised
Approval Date
Aug 2, 2009
EMA

Abilify

Authorization Status
Authorised
Approval Date
Jun 4, 2004
EMA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.